Target intelligence / Profile preview

Mitochondrial quality control pathway (MQC)

Target: MQC
Molecular classification: Other (integrated pathway/process), Includes elements from "Enzyme," "Chaperone," "Protease," "Transcription factor," and "Other" families at the component level

Overview

The mitochondrial quality control pathway is a collective term for a series of interconnected cellular pathways that monitor and maintain mitochondrial function and integrity. These include mechanisms for detecting and repairing mitochondrial damage, removing dysfunctional mitochondrial components via mitophagy, regulating mitochondrial dynamics (fusion and fission), promoting mitochondrial biogenesis, and maintaining proteostasis through chaperones and proteases. Failure or dysfunction in these pathways is implicated in numerous diseases, such as neurodegenerative disorders, cardiovascular diseases, cancer, metabolic syndromes, and inflammatory conditions. Therapeutic interventions aim to enhance or normalize these MQC strategies to protect against disease and cellular dysfunction, but targeting the pathway poses challenges due to its complexity and the central role of mitochondria in basic cell biology.

Other names: Mitochondrial quality control (MQC)MQC pathwaymitochondrial proteostasis pathway

Mechanism of action

Enhancement of mitophagy (removal of damaged mitochondria); Antioxidant protection/ROS detoxification; Stimulation of mitochondrial biogenesis; Promotion of chaperone activity and proteostasis; Regulation of mitochondrial fusion/fission dynamics

Biological functions

Proteostasis (protein homeostasis)Organelle repairApoptosis regulationOxidative phosphorylation maintenanceCellular adaptation to stressCell death prevention

Disease associations

Neurodegenerative disease (e.g., Parkinson’s, Alzheimer’s)Cardiovascular disease (e.g., heart failure, doxorubicin-induced cardiotoxicity)CancerMetabolic diseaseInflammationInfectionOther (multisystemic diseases where mitochondrial dysfunction is implicated)

Safety considerations

Off-target effects from modulating core cellular processesPotential for disrupting cellular energy balanceInterference with normal apoptotic pathways

Interacting drugs

Elamipretide

5 more in the full profile.

Biomarkers

PINK1/parkin pathway markersMitophagy markers (e.g., LC3-II)mtDNA copy number integrityROS levelsPGC1-α expressionMitochondrial membrane potential indicators

Beyond the preview

Go deeper on Mitochondrial quality control pathway (MQC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial quality control pathway (MQC).

Explore the full profile